Caspase-2 is required for cell death induced by cytoskeletal disruption

Oncogene

Volumn 27, Issue 24, 2008, Pages 3393-3404

  Ho, L H ^a   Read, S H ^a   Dorstyn, L ^a   Lambrusco, L ^a   Kumar, S ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Apoptosis; Bax; Bid; Caspase 2 activation; Cytoskeleton; Initiator caspase

Indexed keywords

CASPASE 2; CYTOCHALASIN D; CYTOCHROME C; PACLITAXEL; PROTEIN BAX; PROTEIN BID; VINCRISTINE; ZOLEDRONIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DISRUPTION; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; DRUG INHIBITION; DRUG RESPONSE; IN VITRO STUDY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BONE DENSITY CONSERVATION AGENTS; CARRIER PROTEINS; CASPASE 2; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CRADD SIGNALING ADAPTOR PROTEIN; CYTOCHROMES C; CYTOSKELETON; DIPHOSPHONATES; FIBROBLASTS; IMIDAZOLES; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA;

MUS;

EID: 44149087374     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1211005     Document Type: Article

References (49)

1. Antignani A, Youle RJ. (2006). How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr Opin Cell Biol 18: 685-689.
2. Baliga BC, Read SH, Kumar S. (2004). The biochemical mechanism of caspase-2 activation. Cell Death Differ 11: 1234-1241.
3. Bergeron L, Perez GI, Macdonald G, Shi LF, Sun Y, Jurisicova A et al. (1998). Defects in regulation of apoptosis in caspase-2 deficient mice. Genes Dev 12: 1304-1314.
4. Bhalla KN. (2003). Microtubule-targeted anticancer agents and apoptosis. Oncogene 22: 9075-9086.
5. Bonzon C, Bouchier-Hayes L, Pagliari LJ, Green DR, Newmeyer DD. (2006). Caspase-2-induced apoptosis requires Bid cleavage: a physiological role for Bid in heat shock-induced death. Mol Biol Cell 17: 2150-2157.
6. Butt AJ, Harvey NL, Parasivam G, Kumar S. (1998). Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxy-terminal regions. J Biol Chem 273: 6763-6768.
7. Colussi PA, Harvey NL, Shearwin-Whyatt LM, Kumar S. (1998). Conversion of pro-caspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J Biol Chem 273: 26566-26570.
8. Degterev A, Boyce M, Yuan J. (2003). A decade of caspases. Oncogene 22: 8543-8567.
9. Dorstyn L, Colussi PA, Quinn LM, Richardson H, Kumar S. (1999). DRONC, a novel ecdysone-inducible Drosophila caspase. Proc Natl Acad Sci USA 96: 4307-4312.
10. Ekert P, Read SH, Silke J, Marsden VS, Kaufmann H, Hawkins CJ et al. (2004). Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 165: 835-842.
11. Gourlay CW, Ayscough KR. (2005). The actin cytoskeleton: a key regulator of apoptosis and ageing? Mol Cell Biol 6: 583-589.
12. Green JR. (2005). Bisphosphonates: preclinical review. Oncologist 9: 3-13.
13. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnermri T, Alnemri ES. (2002). Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 277: 13430-13437.
14. Handrick R, Rubel A, Faltin H, Eibl H, Belka C, Jendrossek V. (2006). Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling. Radiother Oncol 80: 199-206.
15. Harvey NL, Butt A, Kumar S. (1997). Functional activation of Nedd2/ICH-1 (caspase-2) is an early process in apoptosis. J Biol Chem 272: 13134-13139.
16. Holleman A, den Boer ML, Kazemier KM, Beverloo HB, von Bergh AR, Janka-Schaub GE et al. (2005). Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood 106: 1817-1823.
17. Kepp O, Rajalingam K, Kimmig S, Rudel T. (2007). Bak and Bax are non-redundant during infection and DNA damage-induced apoptosis. EMBO J 26: 825-834.
18. Kong JY, Rabkin SW. (2005). The association between RhoB and caspase-2: changes with lovastatin-induced apoptosis. Biochem Cell Biol 83: 608-619.
19. Kumar S. (1995). Inhibition of apoptosis by antisense Nedd2 expression. FEBS Lett 368: 69-72.
20. Kumar S. (2007). Caspase function in programmed cell death. Cell Death Differ 14: 32-43.
21. Kumar S, Doumanis J. (2000). The fly caspases. Cell Death Differ 7: 1039-1044.
22. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA. (1994). Induction of apoptosis by the mouse Nedd2 gene which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev 8: 1613-1626.
23. Kumar S, Tomooka Y, Noda M. (1992). Identification of a set of genes with developmentally down-regulated gene expression in the mouse brain. Biochem Biophys Res Commmun 185: 1155-1161.
24. Kumar S, Vaux DL. (2002). A Cinderella caspase takes center stage. Science 297: 1290-1291.
25. Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P. (2002). Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 9: 358-361.
26. Lassus P, Opitz-Araya X, Lazebnik Y. (2002). Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297: 1352-1354.
27. Lavrik IN, Golks A, Baumann S, Krammer PH. (2006). Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis. Blood 108: 559-565.
28. Marsden VS, Ekert PG, Van Delft M, Vaux DL, Adams JM, Strasser A. (2004). Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol 165: 775-780.
29. Martin SS, Vouri K. (2004). Regulation of Bcl-2 proteins during anoikis and amorphosis. Biochem Biophys Acta 1692: 145-157.
30. Mhaidat NM, Wang Y, Kiejda KA, Zhang XD, Hersey P. (2007). Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol Cancer Ther 6: 752-761.
31. Milleron RS, Bratton SB. (2006). Heat shock induces apoptosis independently of any known initiator caspase-activating complex. J Biol Chem 281: 16991-17000.
32. O'Reilly LA, Ekert P, Harvey N, Marsden V, Cullen L, Vaux DL et al. (2002). Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is mediated by Apaf-1 and caspase-9. Cell Death Differ 9: 832-846.
33. Panaretakis T, Laane E, Pokrovskaja K, Bjorklund AC, Moustakas A, Zhivotovsky B et al. (2005). Doxorubicin requires the sequential activation of caspase-2, protein kinase C delta, and c-Jun NH2-terminal kinase to induce apoptosis. Mol Biol Cell 16: 3821-3831.
34. Paroni G, Henderson C, Schneider C, Brancolini C. (2002). Caspase-2 can trigger cytochrome c release and apoptosis from the nucleus. J Biol Chem 277: 15147-15161.
35. Robertson JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S. (2002). Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 277: 29803-29809.
36. Shearwin-Whyatt L, Baliga B, Doumanis J, Kumar S. (2001). Chimeric caspase molecules with potent cell killing activity in apoptosis-resistant cells. Biochem Biophys Res Commun 282: 1114-1119.
37. Shearwin-Whyatt LM, Harvey NL, Kumar S. (2000). Subcellular localization of CARD-dependent oligomerization of the death adaptor RAIDD. Cell Death Differ 7: 155-165.
38. Shi YL, Rothfield L. (2006). The bacterial cytoskeleton. Microbiol Mol Biol Rev 70: 729-754.
39. Shin S, Lee Y, Kim W, Ko H, Choi H, Kim K. (2005). Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 124: 3532-3542.
40. Theirault RL. (2003). Zoledronic acid uses in bone disease. Expert Rev Anticancer Ther 3: 157-166.
41. Tinel A, Tschopp J. (2004). The PIddosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304: 843-846.
42. Troy CM, Rabacchi SA, Hohl JB, Angelastro JM, Greene LA, Shelanski ML. (2001). Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J Neurosci 21: 5007-5016.
43. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. (1994). Ich-1, an Ice/ced3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739-750.
44. Wang YF, Chen CY, Chung SF, Chiou YH, Lo HR. (2004). Involvement of oxidative stress and caspase-2 activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells. Cancer Chemother Pharmacol 54: 322-330.
45. Waterhouse NJ, Trapani JA. (2003). A new quantitative assay for cytochrome c release in apoptotic cells. Cell Death Differ 10: 853-855.
46. Wennerberg K, Rossman KL, Der CJ. (2005). Ras superfamily at a glance. J Cell Sci 118: 843-846.
47. Yeung BH, Huang DC, Sinicrope FA. (2006). PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and a caspase-2-dependent mitochondrial permeabilization and apoptosis in pancreatic cancer cells. J Biol Chem 281: 11923-11932.
48. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75: 641-652.
49. Zhivotovsky B, Orrenius S. (2005). Caspase-2 function in response to DNA damage. Biochem Biophys Res Commun 331: 859-867.